April 2012
Table of Contents
Abbott Laboratories
| Abbott Laboratories | Abstract |
| Nigel Borshell |
AstraZeneca
| AstraZeneca | Abstract |
| Nigel Borshell |
Bayer Healthcare
| Bayer Healthcare | Abstract |
| Nigel Borshell |
Bristol-Myers Squibb
| Bristol-Myers Squibb | Abstract |
| Nigel Borshell |
Eli Lilly
| Eli Lilly | Abstract |
| Nigel Borshell |
GlaxoSmithKline
| GlaxoSmithKline | Abstract |
| Nigel Borshell |
Johnson & Johnson
| Johnson and Johnson | Abstract |
| Nigel Borshell |
Merck & Co
| Merck | Abstract |
| Nigel Borshell |
Novartis
| Novartis | Abstract |
| Nigel Borshell |
Pfizer
| Pfizer | Abstract |
| Nigel Borshell |
Roche
| Roche | Abstract |
| Nigel Borshell |
Sanofi
| Sanofi | Abstract |
| Nigel Borshell |
Quarterly Review
| Sanofi Climbs the Deal Activity League Table | Abstract |
| Heather Cartwright |